4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-14-034312
President and CEO bought 16,000 shares at $6.32 ($101,120)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard President and CEO | 2014-10-15 | Purchase | +16,000 | $6.32 | $101,120 | 260,173 | D: show line 1 in the form |
| Open-market purchases · 16,000 sh · avg $6.32 · $101,120 | |||||||
Loading xslF345X03/rrd417655.xml…